Epitalon Peptide in Canada: The AEDG Tetrapeptide and Its Evidence

Epitalon is about as small as a research peptide gets: four amino acids, under 400 daltons, no unusual residues. That simplicity makes it one of the easiest compounds to verify analytically, and its published record one of the hardest to weigh. For labs buying epitalon peptide in Canada, particularly in multi-vial quantities for longer projects, both halves matter. This review covers the identity data, the single chemical weak point in the sequence, what a good certificate for a very small peptide looks like, and how to read a literature that comes largely from one research tradition.

Epitalon peptide in Canada: one molecule, several spellings

The compound is sold and cited under a handful of names, which can make catalogues and databases look as if they describe different substances. They do not.

When searching the literature or comparing suppliers, try every spelling plus the one-letter sequence. For purchasing records, write the sequence and mass on the order so the name variant used on a label never becomes a source of doubt.

From pineal extract to a defined sequence

Its starting point was epithalamin, a crude mixture of peptides obtained from the pineal glands of cattle; epitalon was made as a synthetic stand-in for it. Extracts are mixtures by nature, and a defined four-residue sequence gave researchers a single, characterisable molecule to work with instead. The distinction matters when reading papers: results obtained with the extract are not evidence about the synthetic tetrapeptide, and the two should not be cited interchangeably.

Why four residues make verification easier

Short sequences leave impurities fewer places to hide. For epitalon that works in the analyst’s favour in three ways:

• Few coupling steps. Solid-phase synthesis of a tetrapeptide involves only a handful of residue additions, so deletion sequences, the typical hidden impurity in long peptides, have limited opportunity to form.
• Large mass shifts. Missing any one residue removes a big share of the molecule: about 57 Da for glycine, 71 for alanine, 115 for aspartate and 129 for glutamate. None of those could be mistaken for the parent peak.
• A clean identity check. Observed versus calculated mass is strong evidence of identity for a molecule this small, much stronger than the same comparison for a long sequence.

The Asp-Gly weak point

The sequence has one notable liability, and it sits at the C-terminal end. Aspartate followed directly by glycine is the arrangement most prone to forming a cyclic succinimide intermediate. When that ring reopens it can give back normal aspartate or produce isoaspartate, in which the peptide backbone runs through the side-chain carboxyl instead.

Isoaspartate has the same mass as the intended molecule, so a mass spectrum will not reveal it. It has to be separated chromatographically. The succinimide intermediate itself sits about 18 Da below the parent and may show up as a minor peak. The reaction proceeds faster in solution than in dry powder, faster at higher temperatures, and at a rate that depends on pH. Practical consequences:

1. Keep vials lyophilised and cold until needed.
2. Prepare analytical solutions shortly before use rather than leaving them on the bench.
3. If a stored lot shows a growing peak close to the main one, suspect isomerisation first.

The sequence contains no methionine, cysteine or tryptophan, so the oxidation routes that affect many other peptides do not apply.

Chromatography and counter-ions for a very small peptide

Epitalon is small, polar and carries two acidic side chains. On a standard C18 column it may come off almost unretained, near the void, which is exactly where salts and small-molecule contaminants crowd together. Methods for this kind of analyte often use stationary phases that tolerate highly aqueous conditions, or adjust ion pairing to improve retention.

With no aromatic residues, the peptide barely absorbs at 280 nm. Purity should be measured in the low-UV region, around 214 nm, where peptide bonds absorb. A certificate quoting purity at 280 nm for this compound is not measuring much.

Counter-ions deserve particular attention. Each trifluoroacetate ion that stays with the peptide after purification weighs roughly 114 Da, equal to almost 30 percent of the mass of a 390 Da molecule. For small peptides, the gap between vial weight and peptide weight is proportionally larger than for long ones, so net peptide content matters when converting vial mass into molar concentration for in-vitro work.

Weighing the published evidence

The research record around epitalon has a recognisable shape, and understanding it is more useful than any list of reported findings:

• A large proportion of the work comes from one research group and its collaborators.
• Many papers were published in Russian, in journals that the major English-language indexes cover only partly.
• Independent replication by unconnected laboratories is comparatively scarce.
• Some widely repeated statements trace back to reviews or abstracts rather than full papers with complete methods.
• Reported outcomes span many different biological measures, and no specific receptor has been established.

None of this shows the findings are wrong. It means citation count is a poor proxy for support, because many citations can lead back to the same few sources. A sensible approach is to treat published claims as hypotheses, look for results reproduced by independent groups, and design new in-vitro work with full controls and fully characterised material. Given how cheap and easy this tetrapeptide is to synthesise and verify, the limited independent replication is itself worth noting.

Receiving and recording a multi-vial order

For a compound this easy to characterise, the paperwork is where most errors creep in. A routine for each shipment:

• Confirm the certificate mass corresponds to AEDG at about 390.35 g/mol, whatever spelling appears on the label.
• Check that purity was measured at a low-UV wavelength.
• Match each vial’s cap and crimp colour to its certificate and log the pairing with lot and vial count.
• Store cold and dry, and keep a whole study on one lot where possible, since isomerisation over time can differ between lots stored differently.

Epitalon 10 mg is third-party tested for purity by HPLC, and certificates are published for some products. With mix-and-match volume pricing, every vial in the cart counts toward the volume break.

Epitalon is sold for in-vitro laboratory research only. It is not for human or veterinary use, and nothing in this review describes or suggests any such use.